検索結果

e due to MGD (Meibomian Gland Dysfunction ), and was previously approved by the Ministry of Health, Labor and Welfare in Japan. It has a preset treatment protocol, and can provide treatment for safety...

ouse developed compound having the development code SJP-0008 was granted by the Ministry of Health, Labor and Welfare (HMLW) on June 19, 2024, as an orphan drug of the Central Retinal Artery Occlusion...

論文投稿実績 | 研究開発活動 | 千寿製薬株式会社

Ophthalmology, Kyoto Prefectural University of Medicine, Kamigyo-ku, Kyoto 602-0841, Japan 5 Senju Laboratory of Ocular Sciences, Senju Pharmaceutical Co., Ltd., Kobe 650-0047, Japan iScience 28, 111...

Compliance System | Our Initiatives for Society/Environment | About Senju | SENJU Pharmaceutical

t the trials with scientific rigor while giving due consideration to animal welfare when the use of laboratory animals is necessary. In addition, SENJU shall submit marketing application for pharmaceu...

requiring instruction by pharmacist, hereinafter this "Product") from Ministry of Health, Labour and Welfare. This Product is the first eye drop in Japan containing “Brimonidine tartrate”, a...